2-21009931-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000233242.5(APOB):​c.6937A>G​(p.Ile2313Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.997 in 1,613,922 control chromosomes in the GnomAD database, including 801,973 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I2313M) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.98 ( 73909 hom., cov: 33)
Exomes 𝑓: 1.0 ( 728064 hom. )

Consequence

APOB
ENST00000233242.5 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.238

Publications

43 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.881807E-6).
BP6
Variant 2-21009931-T-C is Benign according to our data. Variant chr2-21009931-T-C is described in ClinVar as Benign. ClinVar VariationId is 1168905.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000233242.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.6937A>Gp.Ile2313Val
missense
Exon 26 of 29NP_000375.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.6937A>Gp.Ile2313Val
missense
Exon 26 of 29ENSP00000233242.1

Frequencies

GnomAD3 genomes
AF:
0.985
AC:
149910
AN:
152224
Hom.:
73850
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.947
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.995
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.987
GnomAD2 exomes
AF:
0.996
AC:
250044
AN:
251108
AF XY:
0.997
show subpopulations
Gnomad AFR exome
AF:
0.947
Gnomad AMR exome
AF:
0.997
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
0.999
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.998
GnomAD4 exome
AF:
0.998
AC:
1458786
AN:
1461580
Hom.:
728064
Cov.:
53
AF XY:
0.998
AC XY:
725876
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.941
AC:
31495
AN:
33460
American (AMR)
AF:
0.997
AC:
44587
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26122
AN:
26122
East Asian (EAS)
AF:
1.00
AC:
39645
AN:
39658
South Asian (SAS)
AF:
1.00
AC:
86209
AN:
86250
European-Finnish (FIN)
AF:
1.00
AC:
53390
AN:
53390
Middle Eastern (MID)
AF:
0.993
AC:
5724
AN:
5766
European-Non Finnish (NFE)
AF:
1.00
AC:
1111467
AN:
1111832
Other (OTH)
AF:
0.996
AC:
60147
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
175
350
524
699
874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21668
43336
65004
86672
108340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.985
AC:
150027
AN:
152342
Hom.:
73909
Cov.:
33
AF XY:
0.985
AC XY:
73377
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.948
AC:
39388
AN:
41566
American (AMR)
AF:
0.995
AC:
15232
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5175
AN:
5182
South Asian (SAS)
AF:
1.00
AC:
4828
AN:
4830
European-Finnish (FIN)
AF:
1.00
AC:
10626
AN:
10626
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68013
AN:
68044
Other (OTH)
AF:
0.987
AC:
2087
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
115
231
346
462
577
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
916
1832
2748
3664
4580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.995
Hom.:
167275
Bravo
AF:
0.983
TwinsUK
AF:
0.999
AC:
3706
ALSPAC
AF:
1.00
AC:
3853
ESP6500AA
AF:
0.947
AC:
4172
ESP6500EA
AF:
0.999
AC:
8595
ExAC
AF:
0.995
AC:
120801
Asia WGS
AF:
0.997
AC:
3467
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
0.999

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.041
DANN
Benign
0.19
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.17
N
MetaRNN
Benign
0.0000019
T
MetaSVM
Benign
-0.98
T
PhyloP100
-0.24
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.11
N
REVEL
Benign
0.014
Sift
Benign
0.63
T
Sift4G
Benign
0.64
T
Vest4
0.032
MPC
0.033
ClinPred
0.00047
T
GERP RS
-3.8
gMVP
0.17
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs584542; hg19: chr2-21232803; COSMIC: COSV107231948; API